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Rezumat
Efectul aditiv sau de interferenţă dintre VHC şi HSV I, II la pacienţii cu 
hepatită cronică virală C, asociată cu infecţia herpetică 
Cercetările recente sugerează că infecţia herpetică, dezvoltând o stare de 
imunodefi cit, infl uenţează evoluţia hepatitei cronice virale C. Totodată, 
hepatita cronică C, infl uenţând bilanţul Th1/Th2, poate favoriza reactivarea 
infecţiei herpetice latente. În sudiu au fost înrolaţi 144 bolnavi cu hepatită 
cronică virală C: 103 – HVC fără HSV I, II şi 41 HVC cu HSV I, II. La 
pacienţii cu dublă infecţie s-au depistat corelaţii între nivelul anticorpilor 
anti-HSV I, II şi activitatea AST şi ALT, dintre anti-HSV I, II Ig M şi VHC 
(NS5). Au fost depistate corelaţii directe între ALT şi IgG; AST şi IgG; IgM 
şi corelaţii indirecte între ALT şi CD4+; CD3+; AST şi CD4+. Pentru toţi 
pacienţii, HCV/HSV I, II + VHC a fost depistat în reactivare, ceea ce ne 
sugerează ideea că HSV I, II ar fi  un factor de risc pentru progresia hepatitei 
cronice. Rezultatele studiului nostru denotă corelaţii vizibile biochimico-
imunologice la pacienţii cu dublă infecţie, explicându-se posibil prin acţiune 
de interstimulare (efect aditiv) între VHC şi HSV I, II.
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Резюме
Взаимодействие ВГС и герпесной инфекции у больных с хроническим 
гепатитом С 
Изучение механизма взаимодействия между различными системами 
при таких широко распространенных сочетанных патологиях, как 
гепатит С и HSV-инфекция является актуальной проблемой, решение 
которой позволит вскрыть патогенетические особенности процесса. 
Сегодня не вызывает сомнения, что клинические варианты, тяжесть 
заболевания и прогноз во многом зависят от иммунного ответа 
на внедрившийся вирус. Цель работы – в сравнительном аспекте 
установить характер совместного течения хронического гепатита С 
и HSV I, II их клинико-имунологическую симптоматику. Результаты: 
У больных HCV/HSV I, II имеет место дисфункция иммунной системы, 
проявляющаяся дефицитом клеточного (снижение абсолютного 
содержания в крови CD3- CD4-, CD8-, CD 16-клеток) и активацией 
гуморального звеньев иммунитета, угнетением функциональной 
активности лейкоцитов. что свидетельствуют о потенцирующем 
взаимовлиянии этих двух нозологических форм.
Ключевые слова: герпесная инфекция, гепатит С
Introduction
The association between liver diseases and other infectious 
diseases represents one of the most actual research topics. Ana-
lyzing the information contained in specialized publications regar-
ding viral associations, it has been proven that these associations 
determine a pathology with a more severe evolution, for a longer 
period of time and on which background, usually, other compli-
cations may occur [2, 3,4]. The interaction between two viruses in 
the organism may develop as either an inter stimulation action 
80
BOLILE FICATULUI
(additive effect) or removal of one virus by the other 
one (interference effect) [9].  
It has been proven that that the seropositive in-
dividuals for HSV I, II and those with genital ulcerative 
diseases present a higher risk in getting the infection 
with VHC [5, 6, 7]. The recent researches suggest that 
the herpetic infection, by creating a specific state of 
immunodeficiency, may hasten the evolution of the 
viral chronic hepatitis C [3, 9]. In turn, the viral chronic 
viral hepatitis C, as alternates the balance Th1/Th2, 
would create favorable circumstances for the reacti-
vation of the latent herpetic infection. Most previous 
studies have focused on alternative hypothesis, 
which is whether herpes virus infections promote 
HCV replications and thereby results in accelerated 
progression of liver disease due to HCV (especially 
on HCV positive liver transplant recipients) [9].
Objectives
• To assess the biochemical- immunological 
particularities of patients with chronic hepatitis C 
associated with HSV type I and II compared with pa-
tients with chronic hepatitis C with HSV – negative.
• To evaluate the correlations between bi-
ochemical parameters and humoral and cellular 
immunological indicators of patients with chronic 
hepatitis C HSV I, II positive compared with patients 
with chronic hepatitis C HSV I, II negative. 
Material and methods
The clinical material has been selected based 
on the Clinic Republican Hospital during 2002–2005. 
There were 144 patients enrolled in the research, 
having chronic hepatitis of C viral etiology, from 
different regions of the country, who were divided 
in two groups (depending on the presence or absen-
ce of the herpetic infection, type I, II): 103 patients 
with viral chronic hepatitis C, without the herpetic 
infection; 41 patients with viral chronic hepatitis C, 
in association with the herpetic infection type I, II. At 
the same time, in this research have been included: 
20 more patients with the herpetic infection type I, 
II and 20 people served as healthy group. 
Before giving the hepatitis diagnosis, a complex 
of laboratory: biochemical parameters, serological 
markers (antibodies anti VHC Ig G, anti VHC Ig M, 
ARN VHC quantitative; and anti HSV I+II Ig G and 
Ig M), parameters for humoral and cellular immu-
nological status and instrumental researches were 
performed. The value of the indices’ immune para-
meters was used to determine the degree and the 
type of immune disorders using the absolute value 
T lymphocytes - CD3, CD 4, CD8 (Zemskii A.) [1, 8]: 
(the indicator value of a patient/the indicator value 
of a healthy person) – 1 x 100. If the obtained value 
is negative, marked with a “-“, then the patient has 
immune insufficiency. If the patient’s result is mar-
ked with “+”, it stands for the hyper function of the 
immune system.  
± 1-33% – immune disorders, 1st degree; 34-66% 
– immune disorders, 2nd degree; 66% or more 
– immune disorders, 3rd degree.
Results
To the patients with chronic hepatitis C in 
association with the HSV I, II were identified of bi-
ochemical changes which are being noticed by the 
increased activity of the AST and Rittis index at 1/2 of 
the patients. There have been recorded differences 
of ALT and AST values, depending on the phase of 
the herpetic infection, so in the active phase of the 
herpetic infection (n=33) there have been obtained 
higher levels of ALT (p<0.05), AST (p<0.05), versus the 
patients with the herpetic infection in the inactive 
phase. 
The evaluation of the parameters that illustrate 
the activity of the humoral immunity in the group 
of patients with chronic hepatitis C in association 
with the HSV type I and II, highlighted the following 
ideas:
- From the concentration of different groups 
of immunoglobulin, it’s distinguished a more 
specific variation for the groups Ig A and Ig G; 
the concentration of IgA was high at the pati-
ents with mixed infections, overcoming 1.2 of 
the analogic parameter at the patients with 
VHC (mono infection), p<0.05 and 1.5 of those 
patients from the healthy group, p<0.01.
- The variations of the serum level of Ig G were 
obvious, this way an increased value of this 
factor was recorded at the patients with mixed 
infections, versus those with mono infection, 
p<0.05 and from the healthy group, p<0.05.
- The absolute value of CD20+ lymphocytes at the 
patients with VHC+HSV I, II has the tendency to 
grow, being considered as high for more than 
half of the patients.
- The leukocyte /B lymphocyte ratio at the pa-
tients with associated infections, constituted 
-16.9 ± 2.07, having differences statistically 
veracious with a homonymous factor from the 
healthy group people - 29.1 ± 0.25, p<0.001.
- The immunoreglator index (CD3/CD4) at the 
patients with chronic hepatitis C and HSV I, 
II constituted 1.6 ± 0.14 compared with the 
same index in patients with chronic hepatitis 
C without HSV I, II – 4.08 ± 0.23. 
According to our date, we suggest using the 
leukocytes/B-lymphocytes ratio and immunoregla-
tor index are a simple indicators of immunoseverity 
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in patients with chronic hepatitis C associated with 
HSV I, II.
The patients with viral chronic hepatitis C in 
association with the HSV I, II developed a deficiency 
of T lymphocytes, not only taking them from the 
T-helpers (CD4) but also T-suppressors (CD8). 
- Between the characteristic parameters of the 
patients with VHC with HSV I, II and those with 
VHC, have been proven statistical differences 
regarding the absolute number of T CD3+. T 
CD3+ was 1.7 times lower at the patients with 
VHC + HSV I+II than at the patients with mono 
infection.
- T CD4+ at the patients with VHC + HSV I, II re-
corded lower values than at the patients with 
HCVC, p<0.01 as well as versus the healthy 
group, p<0.05.
In the chronic viral C hepatitis associated 
with the HSV I, II, a 2nd degree immune disorder is 
determined, associated with immunodeficiency, 
manifested by the deficiency of T total lymphocytes 
and the subpopulations T CD4+, T CD8+, and the im-
munoreglator factor. In the VHC mono infection was 
found a 2nd degree immune disorder type immune 
stimulation, manifested by the increased of T total 
lymphocytes, the T CD4+and B- lymphocytes and 
immunoreglator index.
After analyzing the given data, at the patients 
with HCVC associated with HSV I, II was established 
a correlations between level anti HSV I, II Ig M with 
activity of AST (r=0.65, p<0.001) and ALT (r=0.86, 
P<0.01). It’s notable the interrelation between the 
anti HSV I, II Ig M with the non-structured part of the 
virus C (NS5) (r=0.44 p<0.01). 
The character of the immunologic and bio-
chemical parameters’ interrelation in the viral C 
hepatitis associated with the herpetic infection type 
I and II, caught our eye. This way, there have been 
found direct correlations between ALT and AST with 
humoral immunologic parameters, as ALT and Ig G 
(r=0.62, p<0.01) and AST with Ig G (r=0.59 P<0, 01) 
and with Ig M (r=0.51, p<0.01). There have been 
found indirect correlations between the levels of 
biochemical markers and the absolute value of the 
immune competent cells: ALT with CD4+ (r=-0.36 
p<0.05), CD3+ (r=-0.49, p<0.01), AST with CD4+ (r=-
0.48 p<0.05), CD3+ (r=-0.42, p<0.01). Our research 
highlights that for all the patients with HCV C +HSV 
I, II VHC is in a reactivation phase, which makes us 
concern that the herpetic infection might hurry the 
evolution of the chronic C hepatitis. 
Discussions
Our study is the first research effectuated in 
the Republic of Moldova regarding the interaction 
between VHC and HSV I.II, evaluated from the expre-
ssivity of liver biochemical syndromes, by evaluating 
the complete immunogram. Our research highlights 
that for all the patients with chronic hepatitis C asso-
ciated with HSV I and II, the virus C is in a reactivation 
phase, which suggest that the herpetic infection 
does appear to promote VHC reactivation. This phe-
nomenon has been called “cofactor type interrelation”. 
The analysis of laboratory data highlights some of 
the particularities that differentiates chronic hepa-
titis C (mono infection) from the chronic hepatitis C 
associated with HSV I, II. This way, the parameters of 
the cytolysis are more pronounced at the patients 
with associated infections than those with mono 
infection. 
Our study demonstrates that latent HSV type 
I, II infection is correlated with necroinflamatory 
activity (ALT, AST) among HCV-infected patients. 
This suggests that a masked HSV type I, II infection 
may interfere with the clinical outcome of chronic 
hepatitis C and favor or accelerate the evolution to 
progression liver disease. Suggestively, our obser-
vations showed that latent HSV type I, II infection 
has some influence on the immunological status of 
chronic HCV infection and in the promotion of HCV 
replication. The mechanism behind these interacti-
ons are unclear. Viral reactivation may merely be a 
marker of a more profound immunosuppressed state 
promoting both HCV and herpes virus reactivation. 
It is common knowledge that HSV particles may 
persist for decades after self-limited acute infection 
and clinical recovery [7, 8, 9]. In addition, infections 
by HSV are ranging from an asymptomatic subclinical 
infection in healthy individuals, and to disseminated 
disease in immunocompromised patients [2, 3, 4].  
Our study showed that in patients with chronic 
hepatitis C associated with HSV I, II developed the 
immunodeficiency compared with patients witho-
ut HSV I, II who developed immune disorder type 
immune stimulation. Alternatively, more specific 
interactions may exist. The researchers demonstrate 
that the primary infection by hepatomimetic viruses 
(HSV, CMV, EBV) is often associated with a vigorous 
T lymphocyte response [4, 5, 8]. HSV reactivation 
develop frequently when T lymphocyte-mediated 
immunity is compromised or HSV may contribute to 
further T lymphocyte hyporesponsiveness [2, 6, 7]. 
We suggest that the latent infections by HSV 
type I, II may play a significant role in the progression 
of liver disease in HCV-infected patients and may 
deteriorate the prognosis of those patients in relati-
on with the response to antiviral therapy. Repeated 
measurements of HSV type I, II infection markers in 
combination with periodic health examinations of 
study subjects may provide useful information on 
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their clinical outcome and identify development 
and progression of liver diseases in HCV infected 
patients. 
Conclusions 
In the chronic viral C hepatitis associated 
with the HSV type I and II, a 2nd degree immune 
disorder is determined, associated with immuno-
deficiency, manifested by the deficiency of T total 
lymphocytes CD3 and the subpopulations T CD4+, T 
CD8+, and the immune regulator factor; leukocyte/ 
B- lymphocyte factor. It is visible the presence of a 
correlation between immunological response and 
biochemical processes that take place in the liver 
at the HCVC+HSV I, II patients, possibly as a result 
of the inter stimulation (additive) effect between 
VHC with HSV. 
The research of herpes virus infection type I, II in 
chronic hepatitis C patients is important because of 
at least 2 reasons: the diagnosis and the precocious 
treatment of this disease, which would prevent any 
other complications to the patients with VHC; and 
the patients with the infectious pathology detected 
may serve as target for the screening of chronic viral 
C hepatitis patients.
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